Making pancreatic cancer an immunotherapy-receptive disease requires identifying select patient subgroups who may benefit.
Jashodeep Datta, MD
Advertisement
Articles by Jashodeep Datta, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Relacorilant/Nab-Paclitaxel Reduces Risk of Death by 35% in Platinum-Resistant Ovarian Cancer
2
Lesions in Radiated/Non-Radiated Fields Achieve Similar Responses with Tisotumab Vedotin in Cervical Cancer
3
Minimal Risk of Liver Failure Identified With Theranostics in GEP-NETs
4
Letrozole Monotherapy Doesn’t Demonstrate PFS Noninferiority in LGSOC
5